Imperial College London
Alternate

ProfessorAndrewNicholson

Faculty of Medicine, National Heart & Lung Institute

Honorary Professor of Respiratory Pathology
 
 
 
//

Contact

 

+44 (0)20 7351 8423andrew.nicholson

 
 
//

Location

 

2119Sydney StreetRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Lindsay:2021:10.1038/s41416-021-01407-9,
author = {Lindsay, CR and Shaw, EC and Moore, DA and Rassl, D and Jamal-Hanjani, M and Steele, N and Naheed, S and Dick, C and Taylor, F and Adderley, H and Black, F and Summers, Y and Evans, M and Rice, A and Fabre, A and Wallace, WA and Nicholson, S and Haragan, A and Taniere, P and Nicholson, AG and Laing, G and Cave, J and Forster, MD and Blackhall, F and Gosney, J and Popat, S and Kerr, KM},
doi = {10.1038/s41416-021-01407-9},
journal = {British Journal of Cancer},
pages = {1210--1216},
title = {Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists},
url = {http://dx.doi.org/10.1038/s41416-021-01407-9},
volume = {125},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Over the past 10 years, lung cancer clinical and translational research has been characterised by exponential progress, exemplified by the introduction of molecularly targeted therapies, immunotherapy and chemo-immunotherapy combinations to stage III and IV non-small cell lung cancer. Along with squamous and small cell lung cancers, large cell neuroendocrine carcinoma (LCNEC) now represents an area of unmet need, particularly hampered by the lack of an encompassing pathological definition that can facilitate real-world and clinical trial progress. The steps we have proposed in this article represent an iterative and rational path forward towards clinical breakthroughs that can be modelled on success in other lung cancer pathologies.
AU  - Lindsay,CR
AU  - Shaw,EC
AU  - Moore,DA
AU  - Rassl,D
AU  - Jamal-Hanjani,M
AU  - Steele,N
AU  - Naheed,S
AU  - Dick,C
AU  - Taylor,F
AU  - Adderley,H
AU  - Black,F
AU  - Summers,Y
AU  - Evans,M
AU  - Rice,A
AU  - Fabre,A
AU  - Wallace,WA
AU  - Nicholson,S
AU  - Haragan,A
AU  - Taniere,P
AU  - Nicholson,AG
AU  - Laing,G
AU  - Cave,J
AU  - Forster,MD
AU  - Blackhall,F
AU  - Gosney,J
AU  - Popat,S
AU  - Kerr,KM
DO  - 10.1038/s41416-021-01407-9
EP  - 1216
PY  - 2021///
SN  - 0007-0920
SP  - 1210
TI  - Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists
T2  - British Journal of Cancer
UR  - http://dx.doi.org/10.1038/s41416-021-01407-9
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000692981300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://www.nature.com/articles/s41416-021-01407-9
UR  - http://hdl.handle.net/10044/1/93098
VL  - 125
ER  -
Download